SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-009047
Filing Date
2022-06-30
Accepted
2022-06-30 16:08:42
Documents
14
Period of Report
2022-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr_8k.htm   iXBRL 8-K 36393
  Complete submission text file 0001654954-22-009047.txt   164345

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20220628.xsd EX-101.SCH 5735
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20220628_lab.xml EX-101.LAB 15213
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20220628_cal.xml EX-101.CAL 908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20220628_pre.xml EX-101.PRE 9650
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20220628_def.xml EX-101.DEF 2109
8 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_8k_htm.xml XML 3702
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 221058113
SIC: 2834 Pharmaceutical Preparations